Metformin in cancer: translational challenges
Ryan J.O. Dowling(University Health Network), Pamela J. Goodwin(Lunenfeld-Tanenbaum Research Institute)
Cited by 351
Related Papers
Changes in insulin receptor signaling underlie neoadjuvant metformin administration in breast cancer: a prospective window of opportunity neoadjuvant study
|Breast Cancer Research|2015|118
The role of mTOR signalling in translational control and cancer
|Library and Archives Canada (Government of Canada)|2009|0